On the other hand, the association of Tim-3 gene expression with clinical outcomes appeared dependent on the tumour type: specifically, higher levels of Tim-3 expression in lung and ovarian cancers correlated with improved patient prognosis, while it was associated with less favourable overall survival in patients with gastric cancer. The gene discussed is HAVCR2; the disease is ovarian cancer.